By Byron Kaye SYDNEY, Feb 3 (Reuters) - Sleep-breathing device maker ResMed plans to take global a doctor education program aimed at promoting the screening of patients seeking Ozempic-style weight ...

Nearly five years after the Philips Respironics recall reshaped the CPAP market, respondents to a recent HME Newspoll say ...

DONGGUAN, GUANGDONG, CHINA, January 15, 2026 /EINPresswire.com/ -- As global healthcare regulations tighten and patient ...

Philips says it has completed actionable registrations across sleep therapy and ventilator devices and is closing the U.S. Patient Portal related to its recall as of Jan. 1, 2026.

DONGGUAN, GUANGDONG, CHINA, January 15, 2026 /EINPresswire.com/ -- As global healthcare evolves towards proactive, ...

Add Yahoo as a preferred source to see more of our stories on Google. Inspire Sleep Apnea Innovation Around 22 million Americans have sleep apnea. Traditional continuous positive airway pressure, or ...

For a potentially serious medical condition, it’s remarkable how few people know they have obstructive sleep apnea (OSA). The good news is that for people with a diagnosis, there have never been more ...

Sleep apnea can result in daytime fatigue and irritability. Obstructive Sleep Apnea, defined as having frequent episodes of ...

Sleep apnea is a debilitating disease that many sufferers don’t even realize they have. Those afflicted with the condition ...

There is currently no drug that treats sleep apnea. However, the third clinical trial of AD109 suggests there could be one in the future. Taylor Leamey wrote about all things wellness for CNET, ...

By Siddhi Mahatole Jan 29 (Reuters) - Medical device maker ResMed on Thursday beat Wall Street estimates for second-quarter profit on the back of strong demand for its devices used to manage sleep ...

Breakthrough sleep apnea medication AD109 shows promising results in phase 3 trials, potentially helping 30 million Americans ...